Interleukin(IL)-1/IL-6-inhibitor-associated drug reaction with eosinophilia and systemic symptoms (DReSS) in systemic inflammatory illnesses.
Still disease
biologic therapy
drug reaction with eosinophilia and systemic symptoms
drug-induced lung disease
hemophagocytic lymphohistiocytosis
macrophage activation syndrome
pulmonary hypertension
systemic inflammatory illnesses
Journal
The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220
Informations de publication
Date de publication:
11 Jul 2024
11 Jul 2024
Historique:
received:
06
03
2024
revised:
30
05
2024
accepted:
02
07
2024
medline:
14
7
2024
pubmed:
14
7
2024
entrez:
13
7
2024
Statut:
aheadofprint
Résumé
After introducing interleukin(IL)-1/IL-6 inhibitors, some Still and Still-like patients developed unusual often fatal pulmonary disease. This complication was associated with scoring as DReSS (drug reaction with eosinophilia and systemic symptoms) implicating these inhibitors, although DReSS can be difficult to recognize in the setting of systemic inflammatory disease. We sought to facilitate recognition of IL-1/IL-6 inhibitor-DReSS in systemic inflammatory illnesses (Still/Still-like) by looking at timing and reaction-associated features. We evaluated outcomes of stopping or not-stopping IL-1/IL-6-inhibitors after DReSS reaction began. In an international study collaborating primarily with pediatric specialists, we characterized features of 89 drug-reaction cases versus 773 drug-exposed controls and compared outcomes of 52 cases stopping IL-1/IL-6-inhibitors to 37 cases not-stopping these drugs. Before reaction began, drug-reaction cases and controls were clinically comparable, except for younger disease onset age for reaction cases with pre-existing cardiothoracic comorbidities. After reaction began, increased rates of pulmonary complications and macrophage activation syndrome (MAS), differentiated drug-reaction cases from drug-tolerant controls (p=4.7x10 In systemic inflammatory illnesses, recognition of IL-1/IL-6-inhibitor-associated reactions followed by avoidance of IL-1/IL-6-inhibitors significantly improved outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
After introducing interleukin(IL)-1/IL-6 inhibitors, some Still and Still-like patients developed unusual often fatal pulmonary disease. This complication was associated with scoring as DReSS (drug reaction with eosinophilia and systemic symptoms) implicating these inhibitors, although DReSS can be difficult to recognize in the setting of systemic inflammatory disease.
OBJECTIVE
OBJECTIVE
We sought to facilitate recognition of IL-1/IL-6 inhibitor-DReSS in systemic inflammatory illnesses (Still/Still-like) by looking at timing and reaction-associated features. We evaluated outcomes of stopping or not-stopping IL-1/IL-6-inhibitors after DReSS reaction began.
METHODS
METHODS
In an international study collaborating primarily with pediatric specialists, we characterized features of 89 drug-reaction cases versus 773 drug-exposed controls and compared outcomes of 52 cases stopping IL-1/IL-6-inhibitors to 37 cases not-stopping these drugs.
RESULTS
RESULTS
Before reaction began, drug-reaction cases and controls were clinically comparable, except for younger disease onset age for reaction cases with pre-existing cardiothoracic comorbidities. After reaction began, increased rates of pulmonary complications and macrophage activation syndrome (MAS), differentiated drug-reaction cases from drug-tolerant controls (p=4.7x10
CONCLUSIONS
CONCLUSIONS
In systemic inflammatory illnesses, recognition of IL-1/IL-6-inhibitor-associated reactions followed by avoidance of IL-1/IL-6-inhibitors significantly improved outcomes.
Identifiants
pubmed: 39002722
pii: S2213-2198(24)00692-5
doi: 10.1016/j.jaip.2024.07.002
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
R Aamir
(R)
K Abulaban
(K)
A Adams
(A)
C Aguiar Lapsia
(CA)
A Akinsete
(A)
S Akoghlanian
(S)
M Al Manaa
(M)
A AlBijadi
(A)
E Allenspach
(E)
A Almutairi
(A)
R Alperin
(R)
G Amarilyo
(G)
W Ambler
(W)
M Amoruso
(M)
S Angeles-Han
(S)
S Ardoin
(S)
S Armendariz
(S)
L Asfaw
(L)
N Aviran Dagan
(NA)
C Bacha
(C)
I Balboni
(I)
S Balevic
(S)
S Ballinger
(S)
S Baluta
(S)
L Barillas-Arias
(L)
M Basiaga
(M)
K Baszis
(K)
S Baxter
(S)
M Becker
(M)
A Begezda
(A)
E Behrens
(E)
E Beil
(E)
S Benseler
(S)
L Bermudez-Santiago
(L)
W Bernal
(W)
T Bigley
(T)
C Bingham
(C)
B Binstadt
(B)
C Black
(C)
B Blackmon
(B)
M Blakley
(M)
J Bohnsack
(J)
A Boneparth
(A)
H Bradfield
(H)
J Bridges
(J)
E Brooks
(E)
M Brothers
(M)
H Brunner
(H)
L Buckley
(L)
M Buckley
(M)
M Buckley
(M)
H Bukulmez
(H)
D Bullock
(D)
S Canna
(S)
L Cannon
(L)
S Canny
(S)
V Cartwright
(V)
E Cassidy
(E)
D Castro
(D)
E Chalom
(E)
J Chang
(J)
M Chang
(M)
J Chang
(J)
A Chang-Hoftman
(A)
A Chen
(A)
P Chiraseveenuprapund
(P)
K Ciaglia
(K)
D Co
(D)
E Cohen
(E)
J Collinge
(J)
H Conlon
(H)
R Connor
(R)
K Cook
(K)
A Cooper
(A)
J Cooper
(J)
K Corbin
(K)
C Correll
(C)
R Cron
(R)
M Curry
(M)
A Dalrymple
(A)
E Datyner
(E)
T Davis
(T)
D De Ranieri
(D)
J Dean
(J)
C DeCoste
(C)
F Dedeoglu
(F)
M DeGuzman
(M)
N Delnay
(N)
E DeSantis
(E)
R Devine
(R)
M Dhalla
(M)
A Dhanrajani
(A)
D Dissanayake
(D)
B Dizon
(B)
N Drapeau
(N)
J Drew
(J)
K Driest
(K)
Q Du
(Q)
E Duncan
(E)
K Dunnock
(K)
D Durkee
(D)
J Dvergsten
(J)
A Eberhard
(A)
K Ede
(K)
B Edelheit
(B)
C Edens
(C)
T El Tal
(T)
M Elder
(M)
Y Elzaki
(Y)
S Fadrhonc
(S)
C Failing
(C)
D Fair
(D)
L Favier
(L)
B Feldman
(B)
J Fennell
(J)
P Ferguson
(P)
I Ferguson
(I)
C Figueroa
(C)
E Flanagan
(E)
L Fogel
(L)
E Fox
(E)
M Fox
(M)
L Franklin
(L)
R Fuhlbrigge
(R)
J Fuller
(J)
M Furey
(M)
T Futch-West
(T)
S Gagne
(S)
V Gennaro
(V)
D Gerstbacher
(D)
M Gilbert
(M)
A Gironella
(A)
D Glaser
(D)
I Goh
(I)
D Goldsmith
(D)
S Gorry
(S)
N Goswami
(N)
B Gottlieb
(B)
T Graham
(T)
S Grevich
(S)
T Griffin
(T)
A Grim
(A)
A Grom
(A)
M Guevara
(M)
T Hahn
(T)
O Halyabar
(O)
M Hamda Natur
(MH)
E Hammelev
(E)
T Hammond
(T)
L Harel
(L)
J Harris
(J)
O Harry
(O)
J Hausmann
(J)
A Hay
(A)
K Hays
(K)
K Hayward
(K)
L Henderson
(L)
M Henrickson
(M)
A Hersh
(A)
K Hickey
(K)
L Hiraki
(L)
M Hiskey
(M)
P Hobday
(P)
C Hoffart
(C)
M Holland
(M)
M Hollander
(M)
S Hong
(S)
D Horton
(D)
M Horwitz
(M)
J Hsu
(J)
A Huber
(A)
A Huberts
(A)
J Huggins
(J)
L Huie
(L)
J Hui-Yuen
(J)
M Ibarra
(M)
A Imlay
(A)
L Imundo
(L)
C Inman
(C)
A Jackson
(A)
K James
(K)
G Janow
(G)
S Jared
(S)
Y Jiang
(Y)
L Johnson
(L)
N Johnson
(N)
J Jones
(J)
D Kafisheh
(D)
P Kahn
(P)
K Kaidar
(K)
S Kasinathan
(S)
R Kaur
(R)
E Kessler
(E)
B Kienzle
(B)
S Kim
(S)
Y Kimura
(Y)
D Kingsbury
(D)
M Kitcharoensakkul
(M)
T Klausmeier
(T)
K Klein
(K)
M Klein-Gitelman
(M)
A Knight
(A)
L Kovalick
(L)
S Kramer
(S)
C Kremer
(C)
O Kudas
(O)
T LaFlam
(T)
B Lang
(B)
S Lapidus
(S)
B Lapin
(B)
A Lasky
(A)
C Lawler
(C)
E Lawson
(E)
R Laxer
(R)
P Lee
(P)
P Lee
(P)
T Lee
(T)
A Lee
(A)
E Leisinger
(E)
L Lentini
(L)
M Lerman
(M)
Y Levinsky
(Y)
D Levy
(D)
S Li
(S)
S Lieberman
(S)
L Lim
(L)
E Limenis
(E)
C Lin
(C)
N Ling
(N)
G Lionetti
(G)
R Livny
(R)
M Lloyd
(M)
M Lo
(M)
A Long
(A)
M Lopez-Peña
(M)
D Lovell
(D)
N Luca
(N)
S Lvovich
(S)
A Lytch
(A)
M Ma
(M)
A Machado
(A)
J MacMahon
(J)
J Madison
(J)
M Mannion
(M)
C Manos
(C)
L Mansfield
(L)
B Marston
(B)
T Mason
(T)
D Matchett
(D)
L McAllister
(L)
K McBrearty
(K)
J McColl
(J)
D McCurdy
(D)
K McDaniels
(K)
J McDonald
(J)
E Meidan
(E)
E Mellins
(E)
Z Mian
(Z)
P Miettunen
(P)
M Miller
(M)
D Milojevic
(D)
R Mitacek
(R)
R Modica
(R)
S Mohan
(S)
T Moore
(T)
K Moore
(K)
L Moorthy
(L)
J Moreno
(J)
E Morgan
(E)
A Moyer
(A)
B Murante
(B)
A Murphy
(A)
E Muscal
(E)
O Mwizerwa
(O)
A Najafi
(A)
K Nanda
(K)
N Nasah
(N)
L Nassi
(L)
S Nativ
(S)
M Natter
(M)
K Nearanz
(K)
J Neely
(J)
L Newhall
(L)
A Nguyen
(A)
P Nigrovic
(P)
J Nocton
(J)
B Nolan
(B)
K Nowicki
(K)
R Oakes
(R)
E Oberle
(E)
S Ogbonnaya-Whittesley
(S)
E Ogbu
(E)
M Oliver
(M)
R Olveda
(R)
K Onel
(K)
A Orandi
(A)
J Padam
(J)
A Paller
(A)
N Pan
(N)
J Pandya
(J)
S Panupattanapong
(S)
A Pappo Toledano
(AP)
A Parsons
(A)
J Patel
(J)
P Patel
(P)
A Patrick
(A)
S Patrizi
(S)
S Paul
(S)
J Perfetto
(J)
M Perron
(M)
M Peskin
(M)
L Ponder
(L)
R Pooni
(R)
S Prahalad
(S)
B Puplava
(B)
M Quinlan-Waters
(M)
C Rabinovich
(C)
J Rafko
(J)
H Rahimi
(H)
K Rampone
(K)
S Ramsey
(S)
R Randell
(R)
L Ray
(L)
A Reed
(A)
A Reed
(A)
H Reid
(H)
D Reiff
(D)
S Richins
(S)
M Riebschleger
(M)
E Rife
(E)
M Riordan
(M)
M Riskalla
(M)
A Robinson
(A)
L Robinson
(L)
L Rodgers
(L)
M Rodriquez
(M)
D Rogers
(D)
T Ronis
(T)
A Rosado
(A)
M Rosenkranz
(M)
N Rosenwasser
(N)
H Rothermel
(H)
D Rothman
(D)
E Rothschild
(E)
E Roth-Wojcicki
(E)
K Rouster-Stevens
(K)
T Rubinstein
(T)
J Rupp
(J)
N Ruth
(N)
S Sabbagh
(S)
R Sadun
(R)
L Santiago
(L)
V Saper
(V)
A Sarkissian
(A)
L Scalzi
(L)
J Schahn
(J)
K Schikler
(K)
A Schlefman
(A)
H Schmeling
(H)
E Schmitt
(E)
R Schneider
(R)
G Schulert
(G)
K Schultz
(K)
C Schutt
(C)
C Seper
(C)
R Sheets
(R)
A Shehab
(A)
S Shenoi
(S)
M Sherman
(M)
J Shirley
(J)
M Shishov
(M)
D Siegel
(D)
N Singer
(N)
V Sivaraman
(V)
E Sloan
(E)
C Smith
(C)
J Smith
(J)
E Smitherman
(E)
J Soep
(J)
Mary B Son
(MB)
D Sosna
(D)
C Spencer
(C)
L Spiegel
(L)
J Spitznagle
(J)
H Srinivasalu
(H)
H Stapp
(H)
K Steigerwald
(K)
A Stephens
(A)
Y Sterba Rakovchik
(YS)
S Stern
(S)
B Stevens
(B)
R Stevenson
(R)
K Stewart
(K)
W Stewart
(W)
C Stingl
(C)
M Stoll
(M)
E Stringer
(E)
S Sule
(S)
J Sullivan
(J)
R Sundel
(R)
M Sutter
(M)
C Swaffar
(C)
N Swayne
(N)
R Syed
(R)
T Symington
(T)
G Syverson
(G)
A Szymanski
(A)
S Taber
(S)
R Tal
(R)
A Tambralli
(A)
A Taneja
(A)
T Tanner
(T)
S Tarvin
(S)
L Tate
(L)
A Taxter
(A)
J Taylor
(J)
M Tesher
(M)
T Thakurdeen
(T)
A Theisen
(A)
B Thomas
(B)
L Thomas
(L)
N Thomas
(N)
T Ting
(T)
C Todd
(C)
D Toib
(D)
D Toib
(D)
K Torok
(K)
H Tory
(H)
M Toth
(M)
S Tse
(S)
C Tsin
(C)
J Twachtman-Bassett
(J)
M Twilt
(M)
T Valcarcel
(T)
R Valdovinos
(R)
A Vallee
(A)
H Van Mater
(H)
S Vandenbergen
(S)
L Vannoy
(L)
C Varghese
(C)
N Vasquez
(N)
P Vega-Fernandez
(P)
J Velez
(J)
J Verbsky
(J)
R Verstegen
(R)
E von Scheven
(E)
S Vora
(S)
L Wagner-Weiner
(L)
D Wahezi
(D)
H Waite
(H)
B Walker
(B)
H Walters
(H)
M Waterfield
(M)
A Waters
(A)
P Weiser
(P)
P Weiss
(P)
J Weiss
(J)
E Wershba
(E)
V Westheuser
(V)
A White
(A)
K Widrick
(K)
C Williams
(C)
S Wong
(S)
L Woolnough
(L)
T Wright
(T)
E Wu
(E)
A Yalcindag
(A)
S Yasin
(S)
R Yeung
(R)
K Yomogida
(K)
A Zeft
(A)
Y Zhang
(Y)
Y Zhao
(Y)
A Zhu
(A)
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.